- Report
- February 2024
- 126 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 100 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2023
- 90 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2023
- 110 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2023
- 80 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2023
- 110 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2900EUR$3,000USD£2,491GBP
- Report
- April 2024
- 30 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2900EUR$3,000USD£2,491GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- April 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,699GBP
- Report
- April 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,699GBP
- Report
- April 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,699GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- February 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,699GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- January 2024
- 120 Pages
Global
From €7686EUR$7,950USD£6,602GBP
- Report
- January 2024
- 120 Pages
Global
From €7686EUR$7,950USD£6,602GBP
- Clinical Trials
- January 2024
- 100 Pages
Global
From €1934EUR$2,000USD£1,661GBP
The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more